Intriguingly, dynamic equilibrium exists between mGPX4 and DHODH pathways: tumor cells counteract LPO induced by DHODH inhibition through mGPX4 upregulation, whereas cytosolic GPX4 lacks such compensatory capacity [659]. This evidence concerns the gene GPX4 and neoplasm.